October 1, 2024 Investor Beware: Port Strike Puts Key Stocks And Sectors At Risk
September 30, 2024 Market Movers: Jobs Report and Key Earnings in Focus
September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
September 11, 2024 Top Stocks For Smart Investment Choices
Microsoft Stock Is Way Too Expensive Given These Risks Piling Up
Is A. O. Smith A Good Buy Ahead Of Its Q3 Results?
Tesla: I Would Rather ‘Sell The Rumor’
Microsoft: Back To Basics
October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
ImmunoGen (IMGN) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: October 10, 2024 (09:24)
Sector: HealthcareThe share price of ImmunoGen, Inc. (IMGN) now
Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2024, 2025, 2026, 2027, 2028. How much will one ImmunoGen share be worth in 2024 - 2028?
When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.
Historical and forecast chart of ImmunoGen stock
The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.
Long-term forecasts by years.
ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.
ImmunoGen daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct 12 | 31.56 | 31.12 | 31.81 | 2.23 |
| Oct 13 | 31.76 | 31.43 | 32.26 | 2.65 |
| Oct 14 | 31.50 | 31.16 | 31.77 | 1.96 |
| Oct 15 | 31.15 | 30.70 | 31.33 | 2.07 |
| Oct 16 | 31.69 | 31.27 | 31.95 | 2.17 |
| Oct 17 | 32.07 | 31.61 | 32.50 | 2.82 |
| Oct 18 | 32.13 | 31.88 | 32.61 | 2.30 |
| Oct 19 | 32.01 | 31.64 | 32.28 | 2.02 |
| Oct 20 | 32.08 | 31.88 | 32.57 | 2.15 |
| Oct 21 | 31.94 | 31.71 | 32.15 | 1.39 |
| Oct 22 | 32.02 | 31.64 | 32.21 | 1.80 |
| Oct 23 | 32.65 | 32.26 | 32.86 | 1.88 |
| Oct 24 | 32.38 | 32.12 | 32.66 | 1.67 |
| Oct 25 | 32.47 | 31.95 | 32.97 | 3.19 |
| Oct 26 | 32.38 | 32.20 | 32.83 | 1.95 |
| Oct 27 | 32.67 | 32.29 | 32.85 | 1.72 |
| Oct 28 | 32.80 | 32.44 | 33.28 | 2.59 |
| Oct 29 | 33.12 | 32.93 | 33.58 | 1.99 |
| Oct 30 | 32.99 | 32.54 | 33.47 | 2.86 |
| Oct 31 | 32.85 | 32.51 | 33.16 | 1.98 |
| Nov 01 | 32.73 | 32.40 | 33.08 | 2.08 |
| Nov 02 | 32.54 | 32.07 | 32.96 | 2.78 |
| Nov 03 | 32.61 | 32.19 | 33.11 | 2.86 |
| Nov 04 | 33.01 | 32.53 | 33.53 | 3.06 |
| Nov 05 | 32.84 | 32.57 | 33.36 | 2.42 |
| Nov 06 | 32.53 | 32.33 | 33.02 | 2.15 |
| Nov 07 | 32.48 | 32.17 | 32.79 | 1.92 |
| Nov 08 | 32.64 | 32.26 | 33.06 | 2.47 |
| Nov 09 | 32.43 | 31.94 | 32.72 | 2.44 |
| Nov 10 | 32.57 | 32.43 | 32.92 | 1.51 |
ImmunoGen Daily Price Targets
ImmunoGen Stock Forecast 10-12-2024.
Forecast target price for 10-12-2024: $31.56.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.183%.
Pessimistic target level: 31.12
Optimistic target level: 31.81
ImmunoGen Stock Forecast 10-13-2024.
Forecast target price for 10-13-2024: $31.76.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.580%.
Pessimistic target level: 31.43
Optimistic target level: 32.26
ImmunoGen Stock Forecast 10-14-2024.
Forecast target price for 10-14-2024: $31.50.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 1.924%.
Pessimistic target level: 31.16
Optimistic target level: 31.77
ImmunoGen Stock Forecast 10-15-2024.
Forecast target price for 10-15-2024: $31.15.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.028%.
Pessimistic target level: 30.70
Optimistic target level: 31.33
ImmunoGen Stock Forecast 10-16-2024.
Forecast target price for 10-16-2024: $31.69.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.123%.
Pessimistic target level: 31.27
Optimistic target level: 31.95
ImmunoGen Stock Forecast 10-17-2024.
Forecast target price for 10-17-2024: $32.07.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.743%.
Pessimistic target level: 31.61
Optimistic target level: 32.50
IMGN (IMGN) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Nov. | 33.10 | 29.93 | 34.94 | 14.35 |
| Dec. | 34.59 | 30.91 | 37.60 | 17.80 |
ImmunoGen forecast for this year
ImmunoGen Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $33.1038. Pessimistic: $29.93. Optimistic: $34.94
ImmunoGen Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $34.5935. Pessimistic: $30.91. Optimistic: $37.60
ImmunoGen (IMGN) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 32.52 | 28.86 | 34.47 | 16.27 |
| Feb | 32.52 | 30.13 | 34.86 | 13.57 |
| Mar | 30.62 | 26.99 | 32.82 | 17.77 |
| Apr | 29.15 | 26.26 | 31.24 | 15.95 |
| May | 27.53 | 26.37 | 30.58 | 13.77 |
| Jun | 29.39 | 25.86 | 31.68 | 18.37 |
| Jul | 28.06 | 25.92 | 29.33 | 11.63 |
| Aug | 29.16 | 26.62 | 30.78 | 13.50 |
| Sep | 28.72 | 26.48 | 31.22 | 15.18 |
| Oct | 29.88 | 27.28 | 33.25 | 17.93 |
| Nov | 29.39 | 26.70 | 30.89 | 13.56 |
| Dec | 31.20 | 29.61 | 32.23 | 8.13 |
ImmunoGen (IMGN) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 31.06 | 27.42 | 32.46 | 15.50 |
| Feb | 31.66 | 30.52 | 32.66 | 6.54 |
| Mar | 33.52 | 31.05 | 37.39 | 16.94 |
| Apr | 31.66 | 28.33 | 34.03 | 16.74 |
| May | 36.26 | 34.47 | 39.04 | 11.70 |
| Jun | 31.10 | 29.28 | 33.29 | 12.05 |
| Jul | 31.75 | 28.27 | 34.27 | 17.51 |
| Aug | 29.51 | 27.16 | 31.81 | 14.61 |
| Sep | 28.36 | 27.38 | 31.59 | 13.33 |
| Oct | 28.02 | 26.63 | 30.46 | 12.56 |
| Nov | 32.01 | 29.37 | 35.13 | 16.40 |
| Dec | 33.21 | 29.28 | 35.70 | 18.00 |
ImmunoGen information and performance
N/A
Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.
EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
